Your browser doesn't support javascript.
loading
Favorable survival after allogeneic stem cell transplantation with reduced-intensity conditioning regimens for relapsed/refractory follicular lymphoma.
Yano, S; Mori, T; Kanda, Y; Kato, J; Nakaseko, C; Fujisawa, S; Tomita, N; Sakai, R; Shono, K; Saitoh, T; Aotsuka, N; Kobayashi, N; Saito, T; Takahashi, S; Kanamori, H; Okamoto, S.
Afiliación
  • Yano S; Division of Clinical Oncology and Hematology, Department of Internal Medicine, Jikei University School of Medicine, Tokyo, Japan.
  • Mori T; Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.
  • Kanda Y; Division of Hematology, Saitama Medical Center, Jichi Medical University, Saitama, Japan.
  • Kato J; Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.
  • Nakaseko C; Division of Hematology, Department of Clinical Cell Biology, Chiba University Graduate School of Medicine, Chiba, Japan.
  • Fujisawa S; Department of Hematology, Yokohama City University Medical Center, Yokohama, Japan.
  • Tomita N; Department of Hematology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
  • Sakai R; Department of Medical Oncology, Kanagawa Cancer Center, Yokohama, Japan.
  • Shono K; Department of Hematology, Chiba Aoba Municipal Hospital, Chiba, Japan.
  • Saitoh T; Department of Medicine and Clinical Science, Gunma University Graduate School of Medicine, Maebashi, Japan.
  • Aotsuka N; Department of Hematology, Narita Red Cross Hospital, Chiba, Japan.
  • Kobayashi N; Leukemia Research Center, Saiseikai Maebashi Hospital, Maebashi, Japan.
  • Saito T; Division of Clinical Oncology and Hematology, Department of Internal Medicine, Jikei University School of Medicine, Tokyo, Japan.
  • Takahashi S; Division of Molecular Therapy, The Advanced Clinical Research Center, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
  • Kanamori H; Department of Hematology, Kanagawa Cancer Center, Yokohama, Japan.
  • Okamoto S; Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.
Bone Marrow Transplant ; 50(10): 1299-305, 2015 Oct.
Article en En | MEDLINE | ID: mdl-26168068
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trasplante Homólogo / Linfoma Folicular / Trasplante de Células Madre Hematopoyéticas / Acondicionamiento Pretrasplante Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Bone Marrow Transplant Asunto de la revista: TRANSPLANTE Año: 2015 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trasplante Homólogo / Linfoma Folicular / Trasplante de Células Madre Hematopoyéticas / Acondicionamiento Pretrasplante Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Bone Marrow Transplant Asunto de la revista: TRANSPLANTE Año: 2015 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Reino Unido